Tomáš Klunda

ORCID: 0000-0002-1305-9752
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Carbohydrate Chemistry and Synthesis
  • Glycosylation and Glycoproteins Research
  • Animal Virus Infections Studies
  • interferon and immune responses
  • Cytomegalovirus and herpesvirus research
  • Biochemical Analysis and Sensing Techniques
  • Biochemical and Molecular Research
  • Viral gastroenteritis research and epidemiology
  • Cellular transport and secretion
  • Virus-based gene therapy research
  • Synthesis of Organic Compounds
  • Antifungal resistance and susceptibility
  • Lysosomal Storage Disorders Research
  • Calcium signaling and nucleotide metabolism
  • Hepatitis B Virus Studies
  • Sphingolipid Metabolism and Signaling

Institute of Chemistry of the Slovak Academy of Sciences
2016-2025

Slovak Academy of Sciences
2016-2025

Biomedical Research Center of the Slovak Academy of Sciences
2023

Inhibition of the biosynthesis complex N-glycans in Golgi apparatus influences progress tumor growth and metastasis. α-mannosidase II (GMII) has become a therapeutic target for drugs with anticancer activities. One critical task successful application GMII medical treatments is to decrease their unwanted co-inhibition lysosomal (LMan), weakness all known potent inhibitors. A series novel N-substituted polyhydroxypyrrolidines was synthesized tested modeled GH38 α-mannosidases from Drosophila...

10.1002/cmdc.201700607 article EN ChemMedChem 2018-01-11

Enzymatic assays, molecular modeling and NMR studies of novel 1,4-dideoxy-1,4-imino-<sc>l</sc>-lyxitols provided new information on the GH38 family enzyme inhibitors their selectivity.

10.1039/d1nj01176f article EN New Journal of Chemistry 2021-01-01
Coming Soon ...